These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2408194)

  • 41. [Public health management in invasive meningococcal diseases].
    Ehrhard I; Arndt U
    Gesundheitswesen; 2004 Dec; 66(12):790-5. PubMed ID: 15609213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a meningococcal vaccine.
    Poolman JT
    Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353
    [No Abstract]   [Full Text] [Related]  

  • 43. Conquering the meningococcus.
    Stephens DS
    FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meningococcal vaccine: New product, new recommendations.
    Campos-Outcalt D
    J Fam Pract; 2005 Apr; 54(4):324-6. PubMed ID: 15833222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.
    Jacobsson S; Hedberg ST; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
    Vaccine; 2009 Mar; 27(10):1579-84. PubMed ID: 19162117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meningococcal C conjugate vaccine: the experience in England and Wales.
    Campbell H; Borrow R; Salisbury D; Miller E
    Vaccine; 2009 Jun; 27 Suppl 2():B20-9. PubMed ID: 19477053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of meningococcal vaccine in college freshmen reconsidered.
    Miller JL
    Am J Health Syst Pharm; 1999 Dec; 56(23):2372. PubMed ID: 10595797
    [No Abstract]   [Full Text] [Related]  

  • 49. Pilgrimage to Mecca (Hajj) 1992.
    Commun Dis Rep CDR Wkly; 1992 Mar; 2(10):43. PubMed ID: 1285143
    [No Abstract]   [Full Text] [Related]  

  • 50. Meningococcal vaccine and herd immunity.
    Ozsoylu S
    Lancet; 2000 Mar; 355(9208):1015; author reply 1016. PubMed ID: 10768459
    [No Abstract]   [Full Text] [Related]  

  • 51. Meningococcal vaccine and herd immunity.
    Gikas A; Pediaditis J; Tselentis Y
    Lancet; 2000 Mar; 355(9208):1016. PubMed ID: 10768461
    [No Abstract]   [Full Text] [Related]  

  • 52. [Meningococcal vaccine].
    de Moraes JC
    Rev Saude Publica; 1997 Apr; 31(2):214-6. PubMed ID: 9497571
    [No Abstract]   [Full Text] [Related]  

  • 53. Single-dose packaging of meningococcal vaccine.
    McKinney WP; Barnas GP
    JAMA; 1988 Aug; 260(5):638. PubMed ID: 3392787
    [No Abstract]   [Full Text] [Related]  

  • 54. Reverse vaccinology on the cusp.
    Jones D
    Nat Rev Drug Discov; 2012 Feb; 11(3):175-6. PubMed ID: 22322255
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of gamma globulin on acute respiratory illness in military recruits.
    Chin J; Stallones RA; Lennette EH
    Am J Epidemiol; 1967 Jul; 86(1):193-8. PubMed ID: 4951558
    [No Abstract]   [Full Text] [Related]  

  • 56. Meningococcal vaccine trials.
    Farrington P; Miller E
    Methods Mol Med; 2001; 66():371-93. PubMed ID: 21336769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical trials of the new Norwegian vaccine against diseases caused by Meningococcus B].
    Bjune G; Nøkleby H; Hareide B
    Tidsskr Nor Laegeforen; 1990 Feb; 110(5):614-7. PubMed ID: 2408194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.
    Bjune G; Closs O; Frøholm LO; Grønnesby JK; Høiby EA; Nøkleby H
    NIPH Ann; 1991 Dec; 14(2):81-91; discussion 91-3. PubMed ID: 1812439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.
    Bjune G; Grønnesby JK; Høiby EA; Closs O; Nøkleby H
    NIPH Ann; 1991 Dec; 14(2):125-30; discussion 130-2. PubMed ID: 1812425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.